NCT01294202 2024-08-02A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GISTAstex Pharmaceuticals, Inc.Phase 2 Completed26 enrolled
NCT00812240 2023-02-01Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)AB SciencePhase 3 Terminated335 enrolled